Filing Details
- Accession Number:
- 0001104659-23-115738
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-11-08 16:15:10
- Reporting Period:
- 2023-11-06
- Accepted Time:
- 2023-11-08 16:15:10
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1657312 | Verona Pharma Plc | VRNA | () | 4 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1207107 | R David Ebsworth | 3 More London Riverside London X0 SE1 2RE | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Ordinary Shares | Acquisiton | 2023-11-06 | 160,000 | $1.98 | 844,643 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Footnotes
- Unless otherwise indicated, reported securities are represented by American Depositary Shares ("ADSs"), each of which represents eight (8) Ordinary Shares of the Issuer.
- The price reported is a weighted average price, and is based on the sale price of the ADSs divided by eight (8). The securities were purchased in multiple transactions at per share prices ranging from $1.9131 to $2.00, equivalent to $15.3050 to $16.00 per ADS. The Reporting Person undertakes to provide upon request to the SEC staff, the Issuer, or any shareholder of the Issuer, full information regarding the number of securities purchased at each separate price within the range set forth in this footnote.
- Consists of (i) 844,640 Ordinary Shares represented by 105,580 ADSs; and (ii) 3 Ordinary Shares.
Billionaire Hedge Funds
